282 related articles for article (PubMed ID: 31389669)
21. Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis.
van Dijken BRJ; van Laar PJ; Holtman GA; van der Hoorn A
Eur Radiol; 2017 Oct; 27(10):4129-4144. PubMed ID: 28332014
[TBL] [Abstract][Full Text] [Related]
22. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
[TBL] [Abstract][Full Text] [Related]
23. Investigated diagnostic value of synthetic relaxometry, three-dimensional pseudo-continuous arterial spin labelling and diffusion-weighted imaging in the grading of glioma.
Ge X; Wang M; Ma H; Zhu K; Wei X; Li M; Zhai X; Shen Y; Huang X; Hou M; Liu W; Wang M; Wang X
Magn Reson Imaging; 2022 Feb; 86():20-27. PubMed ID: 34808303
[TBL] [Abstract][Full Text] [Related]
24. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and grading accuracy of
Xiao J; Jin Y; Nie J; Chen F; Ma X
BMC Cancer; 2019 Aug; 19(1):767. PubMed ID: 31382920
[TBL] [Abstract][Full Text] [Related]
26. Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis.
Suh CH; Park JE; Jung SC; Choi CG; Kim SJ; Kim HS
Neuroradiology; 2019 May; 61(5):525-534. PubMed ID: 30666352
[TBL] [Abstract][Full Text] [Related]
27. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of ADC derived from DWI for differentiating high-grade from low-grade gliomas: Systematic review and meta-analysis.
Wang QP; Lei DQ; Yuan Y; Xiong NX
Medicine (Baltimore); 2020 Feb; 99(8):e19254. PubMed ID: 32080132
[TBL] [Abstract][Full Text] [Related]
31. Glioma grading and IDH1 mutational status: assessment by intravoxel incoherent motion MRI.
Wang X; Chen XZ; Shi L; Dai JP
Clin Radiol; 2019 Aug; 74(8):651.e7-651.e14. PubMed ID: 31014573
[TBL] [Abstract][Full Text] [Related]
32. An evidence-based approach to evaluate the accuracy of amide proton transfer-weighted MRI in characterization of gliomas.
Zhao J; Huang S; Xie H; Li W
Medicine (Baltimore); 2019 Mar; 98(10):e14768. PubMed ID: 30855481
[TBL] [Abstract][Full Text] [Related]
33. MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis.
Patel P; Baradaran H; Delgado D; Askin G; Christos P; John Tsiouris A; Gupta A
Neuro Oncol; 2017 Jan; 19(1):118-127. PubMed ID: 27502247
[TBL] [Abstract][Full Text] [Related]
34. Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach.
Falk A; Fahlström M; Rostrup E; Berntsson S; Zetterling M; Morell A; Larsson HB; Smits A; Larsson EM
Neuroradiology; 2014 Dec; 56(12):1031-8. PubMed ID: 25204450
[TBL] [Abstract][Full Text] [Related]
35. Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas.
Conte GM; Altabella L; Castellano A; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Caulo M; Falini A; Anzalone N
Eur Radiol; 2019 Jul; 29(7):3467-3479. PubMed ID: 30972545
[TBL] [Abstract][Full Text] [Related]
36. Ki-67 labeling index and the grading of cerebral gliomas by using intravoxel incoherent motion diffusion-weighted imaging and three-dimensional arterial spin labeling magnetic resonance imaging.
Wang C; Dong H
Acta Radiol; 2020 Aug; 61(8):1057-1063. PubMed ID: 31830431
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of residual/recurrent gliomas from postradiation necrosis with arterial spin labeling and diffusion tensor magnetic resonance imaging-derived metrics.
Razek AAKA; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
Neuroradiology; 2018 Feb; 60(2):169-177. PubMed ID: 29218370
[TBL] [Abstract][Full Text] [Related]
38. The Current Diagnostic Performance of MRI-Based Radiomics for Glioma Grading: A Meta-Analysis.
De Maria L; Ponzio F; Cho HH; Skogen K; Tsougos I; Gasparini M; Zeppieri M; Ius T; Ugga L; Panciani PP; Fontanella MM; Brinjikji W; Agosti E
J Integr Neurosci; 2024 May; 23(5):100. PubMed ID: 38812383
[TBL] [Abstract][Full Text] [Related]
39. Preoperative grading of supratentorial nonenhancing gliomas by high b-value diffusion-weighted 3 T magnetic resonance imaging.
Han H; Han C; Wu X; Zhong S; Zhuang X; Tan G; Wu H
J Neurooncol; 2017 May; 133(1):147-154. PubMed ID: 28439776
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of apparent diffusion coefficient in differentiating between high-grade gliomas and brain metastases.
Caravan I; Ciortea CA; Contis A; Lebovici A
Acta Radiol; 2018 May; 59(5):599-605. PubMed ID: 28835111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
